S&T BANK/PA - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 195 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
S&T BANK/PA ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,107
+17.9%
334,252
-3.7%
1.76%
+26.2%
Q2 2023$7,727
+1.7%
347,260
-1.0%
1.39%
+1.4%
Q1 2023$7,601
+8.1%
350,924
+1.3%
1.37%
+5.7%
Q4 2022$7,033
-99.9%
346,306
-0.9%
1.30%
-25.0%
Q3 2022$8,960,000
-24.4%
349,456
-29.9%
1.73%
-16.9%
Q2 2022$11,855,000
+3.5%
498,539
-2.0%
2.08%
+20.5%
Q1 2022$11,452,000
+12.6%
508,546
-1.0%
1.73%
+16.4%
Q4 2021$10,174,000
+6.5%
513,827
+5.9%
1.48%
+0.3%
Q3 2021$9,552,000
-12.0%
485,376
-1.6%
1.48%
-12.2%
Q2 2021$10,855,000
-8.3%
493,414
-0.8%
1.68%
-12.5%
Q1 2021$11,837,000
-16.6%
497,525
-8.3%
1.93%
-24.5%
Q4 2020$14,196,000
+41.8%
542,677
-5.7%
2.55%
+11.5%
Q3 2020$10,012,000
+6.0%
575,277
+2.5%
2.29%
+6.3%
Q2 2020$9,442,000
+34.9%
561,312
-4.6%
2.15%
+11.6%
Q1 2020$6,999,000
-4.5%
588,620
-2.8%
1.93%
+28.4%
Q4 2019$7,327,000
-17.3%
605,567
-3.1%
1.50%
-21.6%
Q3 2019$8,859,000
+26.1%
625,078
-0.8%
1.92%
+24.5%
Q2 2019$7,023,000
-2.5%
629,826
+2.6%
1.54%
-5.1%
Q1 2019$7,205,000
-14.1%
613,740
-2.2%
1.62%
-16.6%
Q4 2018$8,387,000
-16.5%
627,728
-12.3%
1.94%
+3.7%
Q3 2018$10,039,000
+60.5%
716,023
+80.0%
1.88%
+58.5%
Q2 2018$6,253,000
-10.8%
397,769
-6.7%
1.18%
-5.3%
Q1 2018$7,012,000426,2571.25%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,712,176$123,147,0006.01%
TANAKA CAPITAL MANAGEMENT INC 74,139$1,048,0003.38%
S&T BANK/PA 625,078$8,859,0001.92%
Parallel Advisors, LLC 1,277,851$18,062,0001.55%
AJ WEALTH STRATEGIES, LLC 595,828$8,422,0001.11%
Matarin Capital Management, LLC 891,636$12,603,0000.95%
Capital Impact Advisors, LLC 162,544$2,370,0000.90%
AMI ASSET MANAGEMENT CORP 775,685$10,964,0000.57%
Birchview Capital, LP 50,000$707,0000.47%
Zebra Capital Management LLC 25,409$359,0000.39%
View complete list of CORCEPT THERAPEUTICS INC shareholders